Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Selma Ugurel

Showing results (161-170 of 265) with videos related to

Pageof 27
Sort By:
International Journal of Cancer|May 20, 2014
Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patientsInka Zörnig, Niels Halama, Justo Lorenzo Bermejo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 6, 2024
Effects of an immunosuppressive therapy on the efficacy of immune checkpoint inhibition in metastatic melanoma - An analysis of the prospective skin cancer registry ADOREGCorinna Kochanek, Catharina Gilde, Lisa Zimmer, et al.
Journal for Immunotherapy of Cancer|November 30, 2022
Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREGValerie Glutsch, Patrick Schummer, Hermann Kneitz, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2015
Survival of patients with advanced metastatic melanoma: The impact of novel therapiesSelma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 28, 2024
S1-Guideline Sebaceous CarcinomaJochen Utikal, Pia Nagel, Verena Müller, et al.
European Journal of Cancer (Oxford, England : 1990)|July 31, 2017
Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 25, 2025
Exceptional therapeutic benefit of imatinib in cKIT-mutated mucosal melanoma followed by a KIT mutation lossHannah Zillikens, Corinna Scheib, Vicky Peller, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 2019
Clinical and genetic analysis of melanomas arising in acral sitesAnne Zaremba, Rajmohan Murali, Philipp Jansen, et al.
Nature Communications|March 10, 2017
TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKTRichard Hill, Patricia A Madureira, Bibiana Ferreira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2018
Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell CarcinomaKaiji Fan, Cathrin Ritter, Paul Nghiem, et al.
Pageof 27

Showing results (161-170 of 265) with videos related to

Sort By:
Pageof 27
International Journal of Cancer|May 20, 2014
Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patientsInka Zörnig, Niels Halama, Justo Lorenzo Bermejo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 6, 2024
Effects of an immunosuppressive therapy on the efficacy of immune checkpoint inhibition in metastatic melanoma - An analysis of the prospective skin cancer registry ADOREGCorinna Kochanek, Catharina Gilde, Lisa Zimmer, et al.
Journal for Immunotherapy of Cancer|November 30, 2022
Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREGValerie Glutsch, Patrick Schummer, Hermann Kneitz, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2015
Survival of patients with advanced metastatic melanoma: The impact of novel therapiesSelma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 28, 2024
S1-Guideline Sebaceous CarcinomaJochen Utikal, Pia Nagel, Verena Müller, et al.
European Journal of Cancer (Oxford, England : 1990)|July 31, 2017
Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 25, 2025
Exceptional therapeutic benefit of imatinib in cKIT-mutated mucosal melanoma followed by a KIT mutation lossHannah Zillikens, Corinna Scheib, Vicky Peller, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 2019
Clinical and genetic analysis of melanomas arising in acral sitesAnne Zaremba, Rajmohan Murali, Philipp Jansen, et al.
Nature Communications|March 10, 2017
TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKTRichard Hill, Patricia A Madureira, Bibiana Ferreira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2018
Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell CarcinomaKaiji Fan, Cathrin Ritter, Paul Nghiem, et al.
Pageof 27